| Status | 已發表Published |
| Key stakeholders’ perspectives on pharmacy practice about traditional Chinese medicines in China | |
Yao, D. ; Harnett, J.; Hu, H. ; Ung, O. L. C.
| |
| 2019-06-01 | |
| Source Publication | Advances in Integrative Medicine
 |
| Pages | S113-S113 |
| Abstract | Background: Self-medication with conventional medicines and traditional Chinese medicines (TCM) concurrently is common in China. However, pharmacy practice in this area has not been fully investigated. Purpose: The purpose was to explore key stakeholders’ opinions about pharmacists’ role in the concurrent use of conventional medicines and TCM, barriers that hindered pharmacists from providing care related to such use, and solutions that would support pharmacists extending their role in this area. Methods: Fourteen semi-structured interviews with pharmacists and key stakeholders were conducted in China in 2017. Results: The prevalent use of conventional medicines and TCM concurrently was generally recognized. Confusion about concurrent use and integrative use led to variations in perceived risks and benefits, and attitudes towards the need for pharmacist’s intervention. Nine barriers were identified with a lack of clear definition and guidance about integrative use, a lack of professional image, and a disconnection among pharmacy education, continuing professional development and registration standards being discussed the most. Seven solutions were proposed. Of those, policies that support pharmacy practice, review of competence development and registration criteria, and development of practice guidelines were considered the most important. Various opinions about the role of TCM pharmacists were collected. Conclusion: As the evidence base to support the concurrent use of conventional medicines and TCM continues to unroll, collaborative efforts among the government, professional organizations and universities are needed to strategically plan the development of pharmacy practice in this area. |
| Keyword | pharmacy practice traditional Chinese medicine |
| Language | 英語English |
| The Source to Article | PB_Publication |
| PUB ID | 44022 |
| Document Type | Conference paper |
| Collection | Institute of Chinese Medical Sciences |
| Corresponding Author | Ung, O. L. C. |
| Recommended Citation GB/T 7714 | Yao, D.,Harnett, J.,Hu, H.,et al. Key stakeholders’ perspectives on pharmacy practice about traditional Chinese medicines in China[C], 2019, S113-S113. |
| APA | Yao, D.., Harnett, J.., Hu, H.., & Ung, O. L. C. (2019). Key stakeholders’ perspectives on pharmacy practice about traditional Chinese medicines in China. Advances in Integrative Medicine, S113-S113. |
| Files in This Item: | There are no files associated with this item. | |||||
Items in the repository are protected by copyright, with all rights reserved, unless otherwise indicated.
Edit Comment